Feria/Congreso
Program Highlights
La 18ª edición de BIO-Europe Spring (BES) vuelve del 18 al 20 de marzo de 2024 a Barcelona. Por cuarta vez, la ciudad acogerá la conferencia más importante que se celebra en Europa de la industria biotecnológica y farmacéutica.
La BioRegión de Cataluña contará con un espacio expositivo (stand 20) para dar a conocer los activos más importantes del ecosistema y reafirmar su posición como uno de los principales hubs europeos de salud.
Consulta el programa oficial para obtener información detallada de todas las actividades.
Lunes 18 de marzo
10:00 - 10:30 | Opening remarks - Room 112
- Claire Match – Portfolio Director, Europe, EBD Group
- David Thomas – SVP, Industry Research, Biotechnology Innovation Organization (BIO)
- Miquel Rodríguez Planas – Director of Economic Development and Promotion of Barcelona City Council
- Oriol Alcoba – Director of Industry of the Government of Catalonia
12:00 - 12:30 | Cluster Drinks: Aligning agendas with INNAXE and CEBR – Barcelona BioRegion of Catalonia Booth #20
- Montse Daban - Strategic Foresight and International Relations Director BIOCAT
- Anaïs Le Corvec - Managing Director at Council of European BioRegions (CEBR)
14:00 - 14:45 | For a greener globe: biopharma's journey towards a sustainable future - Exhibit Hall Stage
- Jordi Ferrer - Investment Director, Ship2B Ventures
- Mar Guell - Director, Sustainable Business, Kreab
- Jose Maria Fernandez - Partner, Aliath Bioventures
- Jean-Patrick Hennebelle - SVP, Head of Global Late-Stage Partnering, IPSEN
- Joe Hopcraft - Client Partner, Biotech, IQVIA
- Stephane Thiroloix - CEO, AlgoTx
15:00 - 15:45 | Rising leaders in healthcare: pioneers of creativity and innovation – Room 112
- Lucie Ellis- Executive Director In Vivo, Citeline
- Miquel Vila-Perelló- CEO, Splice Bio
- Sandra Von Meier- Head of Business Development&Licensing, Debiopharm International S.A.
- Angeli Moeller- Head of DIGI (Data and Integration Generating Insights), ROCHE
16:00 - 16:45 | Pharma Company Presentation: Almirall - Room 111
16:15 - 17:00 | Paving the path for groundbreaking ATMP’s - Room 111
- Moderator: Robert Fabregat- CEO - Biocat
- Manel Esteller, Josep Carreras Leukaemia Research Institute
- Lluís Pareras, Invivo Ventures
- Alessandra Magnani, Hospital Sant Joan de Déu
- Toni Andreu, EATRIS
17:30 - 18:30 | Delegation Organizer Reception - Exhibit Hall Stage
19:00 - 21:00 | Evening Reception - MNAC
Martes 19 de marzo
09:30 - 09:45 | Pharma Company Presentation – Sanofi - Room 111
- Peter Dolan - Director of Business Development, Out-Licensing, Sanofi
09:45 - 10:30 | Therapeutic Insights. Room 111 - Neuroscience frontier: identifying opportunities of transformative therapies for neurological conditions
Moderator: Mike Ward - Global Head of Thought Leadership, Decision Resources Group, part of Clarivate
- Khatereh Ahmadi - Head of Search and Evaluation Team, MSD
- Anna Rivkin - VP, Business Development, Immunology, Cardiovascular, and Neuroscience, Bristol Myers Squibb
- Clement Gautier - Head of External Innovation Neuroscience & Rare Disease, IPSEN
- Tania Nadal - Clinical Development Director, Ferrer
10:00 - 10:45 | Business of Biotech. In collaboration with YVC Collective - Room 112
In sync or offbeat: are the expectations of VCs and entrepreneurs aligned?
Moderator: Francisca Peixoto - Co-Founder, LifeLink Ventures
Moderator: Joana Correia - Analyst at Aliath Bioventures, Aliath Bioventures
- Jack O’Meara - CEO, Ochre Bio
- Amanda Wagner - CEO, Immunitas Therapeutics
- Thomas Tan - Principal, Sound Bioventures
- Valerie Vanhooren - CEO, Ona Therapeutics
11:00 - 11:45 | Business of Biotech. New generation of life science venture investing- Room 112
Moderator: Karen Chan - Associate, BioGeneration Ventures
- Laura Lane - VP - Venture Sciences (Europe), Eli Lilly & Co
- Clara Campas - Managing Partner and Co-Founder, Asabys
- Jose Mesa - Partner, Columbus Venture Partners
- Tracy Weightman - Associate Director, Intermediate Capital Group (ICG)
14:00 - 14:45 | Startup Stories, how it started, how it is going - Room 112
- Montserrat Vendrell - Partner Aliath Bioventures
- Laura Soucek - CEO Peptomyc
- Marie Eve-Beaulieu - CSO Peptomyc
15:00 - 17:00 | Startup competition - Room 112
- Stephanie Marrus - Managing Director, University of California San Francisco
- Raul Martin - Partner, Ysios Capital
- Hakan Goker - Managing Director, M Ventures
- Oscar Perez - CSO, Ferrer
16:00 - 16:45 | Unleashing healthcare: the power of AI, data, and personalized therapies. Room 111
Moderator : Bjorn Arvidsson - Managing Director, STUNS Life science
- Jessica Shull - Director of Digital Therapeutics, Vicore Pharma AB
- Victor Guallar - ICREA Research Professor, Barcelona Supercomputing Center
- Prabhu Velusami - Senior Director, Early Innovation Partnering (Retina & Data Sciences), Johnson & Johnson Innovation
- Friedrich Von Bohlen - Co-Founder and CEO, Molecular Health GmbH
- Amparo Cuellar - Business Development Director, BioLizard
16:00 - 16:30 | Talent is the new gravity: lessons from Barcelona - Exhibit hall stage
- Koen Vandercaveye- Director of Investment Promotion, Barcelona&Partners
- Valerie Vanhhooren- CEO Ona Therapeutics
- Sonia Velasco- Partner, Cuatrecasas
- Gonzalo Parra- Bioinformatics Researcher. Barcelona Supercomputing Center
- Juan Diego Casas- Global Talent Scout, AstraZeneca
18:00 - 19:00 | Exhibitor Reception with Josep Sanfeliu in the piano – Barcelona BioRegion of Catalonia Booth #20
- Josep Ll. Sanfeliu- Managing Partner, Asabys Partners
Miércoles 20 de marzo
11:00 - 11:45 | Business development round-up “have we got a deal? - key takeaways from this week's partnering meetings”
Moderator: Mike Ward - Global Head of Thought Leadership, Decision Resources Group (Part of Clarivate)
- Carlos Buesa - CEO, Oryzon Genomics
- Claudia Blattner - VP and Business Development, Immatics Biotechnologies GmbH
- Jeremy Benattar - Marketing Strategy Director, Adocia
- Selwin Ho - CEO, Medigene
- Patrick Meyer - Senior Director Global Strategic BD, Rentschler Biopharma SE
16:00 | Closing reception - Barcelona BioRegion of Catalonia Booth #20